BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32252709)

  • 1. Non-paraneoplastic autoimmune retinopathy that developed in fellow eye 10 years after onset in first eye: a case report.
    Miura G; Baba T; Iwase T; Ohde H; Kanda A; Saito W; Ishida S; Yamamoto S
    BMC Ophthalmol; 2020 Apr; 20(1):132. PubMed ID: 32252709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Paraneoplastic Autoimmune Retinopathy: The First Case Report in Korea.
    Choi EY; Kim M; Adamus G; Koh HJ; Lee SC
    Yonsei Med J; 2016 Mar; 57(2):527-31. PubMed ID: 26847311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
    Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
    Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune retinopathy associated with colonic adenoma.
    Saito W; Kase S; Ohguro H; Ishida S
    Graefes Arch Clin Exp Ophthalmol; 2013 May; 251(5):1447-9. PubMed ID: 22886094
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-paraneoplastic related retinopathy: clinical challenges and review.
    Takiuti JT; Takahashi VKL; Xu CL; Jauregui R; Tsang SH
    Ophthalmic Genet; 2019 Aug; 40(4):293-297. PubMed ID: 31394964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression.
    Karatsai E; Robson AG; Taylor SRJ
    JAMA Ophthalmol; 2019 May; 137(5):564-567. PubMed ID: 30896772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic retinopathy associated with systemic follicular cell lymphoma.
    Bhavsar KV; Hedges T; Thirkill CE; Reichel E
    Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):373-6. PubMed ID: 25835308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cystoid macular edema as a marker in the progression of non-paraneoplastic autoimmune retinopathy.
    Finn AP; Thomas AS; Stinnett SS; Keenan RT; Grewal DS; Jaffe GJ
    Graefes Arch Clin Exp Ophthalmol; 2018 Oct; 256(10):1867-1873. PubMed ID: 30128606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune retinopathy and antiretinal antibodies: a review.
    Grewal DS; Fishman GA; Jampol LM
    Retina; 2014 May; 34(5):827-45. PubMed ID: 24646664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unilateral manifestation of autoimmune retinopathy.
    Almeida DR; Chin EK; Niles P; Kardon R; Sohn EH
    Can J Ophthalmol; 2014 Aug; 49(4):e85-7. PubMed ID: 25103665
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoimmune retinopathy.
    Braithwaite T; Vugler A; Tufail A
    Ophthalmologica; 2012; 228(3):131-42. PubMed ID: 22846442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to transient receptor potential cation channel, subfamily M, member 1 in a Japanese patient with melanoma-associated retinopathy.
    Morita Y; Kimura K; Fujitsu Y; Enomoto A; Ueno S; Kondo M; Sonoda KH
    Jpn J Ophthalmol; 2014 Mar; 58(2):166-71. PubMed ID: 24468869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-alpha-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung.
    Dot C; Guigay J; Adamus G
    Am J Ophthalmol; 2005 Apr; 139(4):746-7. PubMed ID: 15808190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune retinopathy with positive anti-recoverin antibodies not associated with neoplasms: Case report.
    Oporto Caroca JI; Oporto Caroca J
    Arch Soc Esp Oftalmol (Engl Ed); 2019 Nov; 94(11):540-544. PubMed ID: 31470998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management.
    Rahimy E; Sarraf D
    Surv Ophthalmol; 2013; 58(5):430-58. PubMed ID: 23969019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune retinopathy.
    Grange L; Dalal M; Nussenblatt RB; Sen HN
    Am J Ophthalmol; 2014 Feb; 157(2):266-272.e1. PubMed ID: 24315290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of autoimmune retinopathies with immunosuppression.
    Ferreyra HA; Jayasundera T; Khan NW; He S; Lu Y; Heckenlively JR
    Arch Ophthalmol; 2009 Apr; 127(4):390-7. PubMed ID: 19365013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-paraneoplastic autoimmune retinopathy: multimodal testing characteristics of 13 cases.
    Khanna S; Martins A; Oakey Z; Mititelu M
    J Ophthalmic Inflamm Infect; 2019 Feb; 9(1):6. PubMed ID: 30806850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal imaging in non-paraneoplastic autoimmune retinopathy.
    Kasongole D; Raval V; Mruthyunjaya P; Narayanan R
    Indian J Ophthalmol; 2019 Jul; 67(7):1171-1173. PubMed ID: 31238443
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of paraneoplastic optic neuropathy and outer retinitis positive for autoantibodies against collapsin response mediator protein-5, recoverin, and α-enolase.
    Saito M; Saito W; Kanda A; Ohguro H; Ishida S
    BMC Ophthalmol; 2014 Jan; 14():5. PubMed ID: 24428923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.